The A930G polymorphism of P22phox (CYBA) gene but not C242T variation is associated with hypertension: A meta-analysis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Qin, Yu Wang ^a   Peng, Jiao ^b   Liang, Bao Yun ^a   Su, Li ^b   Chen, Qing ^a   Xie, Juan Juan ^a   Gu, Lian ^a  

^a GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CYTIDINE; CYTOCHROME B; GUANIDINE; THYMIDINE; CYBA PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; DATA ANALYSIS; DISEASE ASSOCIATION; GENE; GENE FREQUENCY; GENETIC CORRELATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HYPERTENSION; NUCLEIC ACID ANALYSIS; P22PHOX GENE; POPULATION GENETICS; PRACTICE GUIDELINE; SYSTEMATIC REVIEW; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PUBLISHING; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; AMINO ACID SUBSTITUTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; NADPH OXIDASE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS;

EID: 84891955093     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082465     Document Type: Article

References (49)

1. Picon RV, Fuchs FD, Moreira LB, Riegel G, Fuchs SC (2012) Trends in prevalence of hypertension in Brazil: a systematic review with metaanalysis. PLOS ONE 7: e48255. doi:10.1371/journal.pone.0048255.PubMed: 23118964.
2. Ma C, Chen S, You L, Luo Z, Xing C (2012) Development and psychometric evaluation of the Treatment Adherence Questionnaire for Patients with Hypertension. J Adv Nurs 68: 1402-1413. doi:10.1111/j.1365-2648.2011.05835.x. PubMed: 21954893.
3. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K et al. (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2224-2260. doi:10.1016/S0140-6736(12)61766-8. PubMed: 23245609.
4. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD et al. (2012) Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125: e2-e220. doi:10.1161/CIR.0b013e31823ac046. PubMed: 22179539.
5. Centers for Disease Control and Prevention (CDC) (2012) Vital signs: awareness and treatment of uncontrolled hypertension among adults-United States, 2003-2010. MMWR Morb Mortal Wkly Rep 61: 703-709. PubMed: 22951452.
6. Arima H, Barzi F, Chalmers J (2011) Mortality patterns in hypertension. J Hypertens 29 Suppl 1: S3-S7. doi: 10.1097/00004872-201106001-00009. PubMed: 22157565.
7. Lawes CM, Vander Hoorn S, Rodgers A (2008) Global burden of bloodpressure-related disease, 2001. Lancet 371: 1513-1518. doi:10.1016/S0140- 6736(08)60655-8. PubMed: 18456100. (Pubitemid 351626187)
8. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R (2002) Agespecific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360: 1903-1913. doi:10.1016/S0140-6736(02)11911-8. PubMed: 12493255. (Pubitemid 35472129)
9. Clark CE, Taylor RS, Shore AC, Ukoumunne OC, Campbell JL (2012) Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and metaanalysis. Lancet 379: 905-914. doi:10.1016/S0140-6736(11)61710-8. PubMed: 22293369.
10. Iseki K, Kimura Y, Wakugami K, Okumura K, Muratani H et al. (2000) Comparison of the effect of blood pressure on the development of stroke, acute myocardial infarction, and end-stage renal disease. Hypertens Res 23: 143-149. doi:10.1291/hypres.23.143. PubMed: 10770261. (Pubitemid 30326238)
11. Gu Q, Dillon CF, Burt VL, Gillum RF (2010) Association of hypertension treatment and control with all-cause and cardiovascular disease mortality among US adults with hypertension. Am J Hypertens 23: 38-45. doi:10.1038/ajh.2009.191. PubMed: 19851295.
12. Krzesinski JM, Saint-Remy A (2012) Essential hypertension, a complex trait. Rev Med Liege 67: 279-285. PubMed: 22891479.
13. Ehret GB, Caulfield MJ (2013) Genes for blood pressure: an opportunity to understand hypertension. Eur Heart J 34: 951-961. doi: 10.1093/eurheartj/ ehs455. PubMed: 23303660.
14. Dinauer MC, Pierce EA, Bruns GA, Curnutte JT, Orkin SH (1990) Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest 86: 1729-1737. doi:10.1172/JCI114898. PubMed: 2243141. (Pubitemid 20372627)
15. Soccio M, Toniato E, Evangelista V, Carluccio M, De Caterina R (2005) Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants. Eur J Clin Invest 35: 305-314. doi: 10.1111/j.1365-2362.2005.01500.x. PubMed: 15860042. (Pubitemid 40675604)
16. Rae J, Noack D, Heyworth PG, Ellis BA, Curnutte JT et al. (2000) Molecular analysis of 9 new families with chronic granulomatous disease caused by mutations in CYBA, the gene encoding p22(phox). Blood 96: 1106-1112. PubMed: 10910929. (Pubitemid 30616880)
17. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK (1996) p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271: 23317-23321. doi:10.1074/jbc.271.38.23317. PubMed: 8798532. (Pubitemid 26314775)
18. Ambasta RK, Kumar P, Griendling KK, Schmidt HH, Busse R et al. (2004) Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 279: 45935-45941. doi:10.1074/jbc.M406486200. PubMed: 15322091. (Pubitemid 39491586)
19. Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y et al. (2002) Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 91: 1160-1167. doi:10.1161/01.RES.0000046227.65158.F8. PubMed: 12480817. (Pubitemid 36076365)
20. Lassègue B, Clempus RE (2003) Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285: R277-R297. PubMed: 12855411. (Pubitemid 36898897)
21. Griendling KK, Sorescu D, Ushio-Fukai M (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501. doi: 10.1161/01.RES.86.5.494. PubMed: 10720409. (Pubitemid 30165039)
22. Katsuyama M (2010) NOX/NADPH oxidase, the superoxide-generating enzyme: its transcriptional regulation and physiological roles. J Pharmacol Sci 114: 134-146. doi:10.1254/jphs.10R01CR. PubMed: 20838023.
23. Paravicini TM, Touyz RM (2008) NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31 Suppl 2: S170-S180. doi:10.2337/dc08-s247. PubMed: 18227481.
24. Taniyama Y, Griendling KK (2003) Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42: 1075-1081. doi:10.1161/01.HYP.0000100443.09293.4F. PubMed: 14581295. (Pubitemid 37549058)
25. Redón J, Oliva MR, Tormos C, Giner V, Chaves J et al. (2003) Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41: 1096-1101. doi:10.1161/01.HYP.0000068370.21009.38. PubMed: 12707286. (Pubitemid 36548609)
26. Zalba G, San José G, Beaumont FJ, Fortuño MA, Fortuño A et al. (2001) Polymorphisms and promoter overactivity of the p22(phox) gene in vascular smooth muscle cells from spontaneously hypertensive rats. Circ Res 88: 217-222. doi:10.1161/01.RES.88.2.217. PubMed: 11157675. (Pubitemid 32147311)
27. Moreno MU, San José G, Fortuño A, Beloqui O, Redón J et al. (2007) A novel CYBA variant, the-675A/T polymorphism, is associated with essential hypertension. J Hypertens 25: 1620-1626. doi:10.1097/HJH. 0b013e3281ac211d. PubMed: 17620958. (Pubitemid 47056568)
28. Sales ML, Ferreira MC, Leme CA Jr., Velloso LA, Gallani MC et al. (2007) Non-effect of p22-phox-930A/G polymorphism on end-organ damage in Brazilian hypertensive patients. J Hum Hypertens 21: 504-506. PubMed: 17314996. (Pubitemid 46813603)
29. Kokubo Y, Iwai N, Tago N, Inamoto N, Okayama A et al. (2005) Association analysis between hypertension and CYBA, CLCNKB, and KCNMB1 functional polymorphisms in the Japanese population-the Suita Study. Circ J 69: 138-142. doi:10.1253/circj.69.138. PubMed: 15671602. (Pubitemid 40313030)
30. Moreno MU, San José G, Orbe J, Páramo JA, Beloqui O et al. (2003) Preliminary characterisation of the promoter of the human p22(phox) gene: identification of a new polymorphism associated with hypertension. FEBS Lett 542: 27-31. doi:10.1016/S0014-5793(03)00331-4. PubMed: 12729892. (Pubitemid 36555708)
31. Pang J HD (2004) Relationship of the Promoter of NAD(P)H Oxidase p22phox Gene Polymorphism to Hypertension. Chin J Hyper 12: 502-504
32. Ha DW PJ, (2004) Relationship of P22phox gene 930A/G polymorphism to hypertension in elderly patients. Chin J of Hypertens 24: 1122-1124
33. Ji Z LB, Pan SY (2003) Relationship of the p22phox C242T gene polymorphimn to hypertension. Chin J Geriatr Cardiovasc Cerebrovasc Dis 5: 103-105
34. Schreiber R, Ferreira-Sae MC, Tucunduva AC, Mill JG, Costa FO et al. (2012) CYBA C242T polymorphism is associated with obesity and diabetes mellitus in Brazilian hypertensive patients. Diabet Med 29: e55-e61. doi:10.1111/j.1464- 5491.2012.03594.x. PubMed: 22268370.
35. Kuznetsova T, Gavrilov DV, Dudanov IP, Makarevich PI, Balatskii AV et al. (2008) Influence of polymorphism's of endothelial nitric oxide synthase gene and polymorphism of NADPH oxidase gene on development of complications of arterial hypertension. Kardiologiia 48: 27-33.
36. Moreno MU, San José G, Fortuño A, Beloqui O, Díez J et al. (2006) The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension. J Hypertens 24: 1299-1306. doi:10.1097/01.hjh. 0000234110.54110.56. PubMed: 16794479. (Pubitemid 43948329)
37. Hsueh YM, Lin P, Chen HW, Shiue HS, Chung CJ et al. (2005) Genetic polymorphisms of oxidative and antioxidant enzymes and arsenicrelated hypertension. J Toxicol Environ Health A 68: 1471-1484. doi: 10.1080/15287390590967414. PubMed: 16076760. (Pubitemid 41783274)
38. Wang B WX, (2007) Association of the WNK4 gene and CYBA gene polymorphisms with essential hypertension. Central South Univ.
39. Pang J HD, (2005) Association bewteen NAD(p)H oxidase subunit P22phox gene Polymorphysims and Primary hypertension in Wuhan city of Hubei Province. Wuhan Univ.
40. Petrovic D (2013) Association of the-262C/T polymorphism in the catalase gene promoter and the C242T polymorphism of the NADPH oxidase P22phox gene with essential arterial hypertension in patients with diabetes mellitus type 2. Clin Exp Hypertens: ([MedlinePgn:]) PubMed: 23701472.
41. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med 6: e1000097.
42. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748. PubMed: 13655060.
43. DerSimonian R, Kacker R (2007) Random-effects model for metaanalysis of clinical trials: an update. Contemp Clin Trials 28: 105-114. doi:10.1016/j.cct.2006.04.004. PubMed: 16807131. (Pubitemid 44937874)
44. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. doi:10.1016/0197-2456(86)90046-2. PubMed: 3802833. (Pubitemid 17189972)
45. Gryglewski RJ, Palmer RM, Moncada S (1986) Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320: 454-456. doi:10.1038/320454a0. PubMed: 3007998. (Pubitemid 16097810)
46. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C et al. (2002) Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105: 1656-1662. doi:10.1161/01.CIR.0000012748.58444.08. PubMed: 11940543. (Pubitemid 34298608)
47. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87: 1620-1624. doi:10.1073/pnas.87.4.1620. PubMed: 2154753.
48. Ballinger SW, Patterson C, Yan CN, Doan R, Burow DL et al. (2000) Hydrogen peroxide-and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ Res 86: 960-966. doi:10.1161/01.RES.86.9.960. PubMed: 10807868. (Pubitemid 30324308)
49. Panza JA, Quyyumi AA, Brush JE Jr., Epstein SE (1990) Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323: 22-27. doi:10.1056/NEJM199007053230105. PubMed: 2355955. (Pubitemid 20209468)